Consortium et al. found that examination of the sera and CSF of MS patients revealed a positive correlation between EBNA1 concentrations and HLA DRB1*1501 (Zhou et al., 2016; Brutting et al., 2021). Here, HLA-DRB1 is linked to myeloid sarcoma.